{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:59:46Z","timestamp":1782982786100,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","jada.ada.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of the American Dental Association"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.adaj.2020.08.019","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T12:26:55Z","timestamp":1605875215000},"page":"891-902.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Use of low-dose naltrexone in the management of chronic pain conditions"],"prefix":"10.1016","volume":"151","author":[{"given":"Elizabeth","family":"Hatfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Swidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Ashman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.adaj.2020.08.019_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s11481-013-9451-y","article-title":"Treatment of complex regional pain syndrome (CRPS) using low dose naltrexone (LDN)","volume":"8","author":"Chopra","year":"2013","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"issue":"1","key":"10.1016\/j.adaj.2020.08.019_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13181-015-0512-x","article-title":"Naltrexone: not just for opioids anymore","volume":"12","author":"Sudakin","year":"2016","journal-title":"J\u00a0Med Toxicol"},{"issue":"3-4","key":"10.1016\/j.adaj.2020.08.019_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/00952997509005661","article-title":"Naltrexone pharmacology, pharmacokinetics, and metabolism: current status","volume":"2","author":"Verebey","year":"1975","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"10.1016\/j.adaj.2020.08.019_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","article-title":"The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain","volume":"33","author":"Younger","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.adaj.2020.08.019_bib5","first-page":"56","article-title":"Bernard Bihari, MD: low-dose naltrexone for normalizing immune system function","volume":"19","author":"Bihari","year":"2013","journal-title":"Altern Ther Health Med"},{"issue":"3","key":"10.1016\/j.adaj.2020.08.019_bib6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/phar.2086","article-title":"The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn's disease, and other chronic pain disorders","volume":"38","author":"Patten","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.adaj.2020.08.019_bib7","first-page":"131","article-title":"Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain","volume":"33","author":"Matsuda","year":"2019","journal-title":"J\u00a0Anesth"},{"issue":"3","key":"10.1016\/j.adaj.2020.08.019_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/glia.20928","article-title":"Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury","volume":"58","author":"Lehnardt","year":"2010","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.adaj.2020.08.019_bib9","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/j.pain.0000000000001306","article-title":"Targeting toll-like receptor-4 (TLR4)-an emerging therapeutic target for persistent pain states","volume":"159","author":"Bruno","year":"2018","journal-title":"Pain"},{"issue":"22","key":"10.1016\/j.adaj.2020.08.019_bib10","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1242\/dev.129304","article-title":"Glia in mammalian development and disease","volume":"142","author":"Zuchero","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.adaj.2020.08.019_bib11","series-title":"Central Pain Syndrome","author":"Dydyk","year":"2020"},{"issue":"6","key":"10.1016\/j.adaj.2020.08.019_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"suppl 1","key":"10.1016\/j.adaj.2020.08.019_bib13","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","volume":"154","author":"Ji","year":"2013","journal-title":"Glia and pain: is chronic pain a gliopathy? Pain"},{"issue":"43","key":"10.1016\/j.adaj.2020.08.019_bib14","doi-asserted-by":"crossref","first-page":"16773","DOI":"10.1073\/pnas.0801793105","article-title":"Activation of P2X7 receptors in glial satellite cells reduces pain through downregulation of P2X3 receptors in nociceptive neurons","volume":"105","author":"Chen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.adaj.2020.08.019_bib15","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s11064-012-0801-6","article-title":"Role of astrocytes in pain","volume":"37","author":"Chiang","year":"2012","journal-title":"Neurochem Res"},{"issue":"34","key":"10.1016\/j.adaj.2020.08.019_bib16","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1523\/JNEUROSCI.2260-07.2007","article-title":"Astroglial glutamate-glutamine shuttle is involved in central sensitization of nociceptive neurons in rat medullary dorsal horn","volume":"27","author":"Chiang","year":"2007","journal-title":"J\u00a0Neurosci"},{"issue":"7070","key":"10.1016\/j.adaj.2020.08.019_bib17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature04223","article-title":"BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain","volume":"438","author":"Coull","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.adaj.2020.08.019_bib18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bbi.2006.11.011","article-title":"Satellite glial cells in sensory ganglia: their possible contribution to inflammatory pain","volume":"21","author":"Dublin","year":"2007","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.adaj.2020.08.019_bib19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nurt.2010.05.016","article-title":"Targeting astrocyte signaling for chronic pain","volume":"7","author":"Gao","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"22","key":"10.1016\/j.adaj.2020.08.019_bib20","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1523\/JNEUROSCI.0176-07.2007","article-title":"Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain","volume":"27","author":"Guo","year":"2007","journal-title":"J\u00a0Neurosci"},{"issue":"2","key":"10.1016\/j.adaj.2020.08.019_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0306-4522(02)00279-8","article-title":"Glial cell plasticity in sensory ganglia induced by nerve damage","volume":"114","author":"Hanani","year":"2002","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.adaj.2020.08.019_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S1740925X10000098","article-title":"Can satellite glial cells be therapeutic targets for pain control?","volume":"6","author":"Jasmin","year":"2010","journal-title":"Neuron Glia Biol"},{"issue":"4","key":"10.1016\/j.adaj.2020.08.019_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1017\/S1740925X07000403","article-title":"Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF\/JNK pathway","volume":"2","author":"Ji","year":"2006","journal-title":"Neuron Glia Biol"},{"key":"10.1016\/j.adaj.2020.08.019_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1744-8069-3-33","article-title":"p38 MAPK, microglial signaling, and neuropathic pain","volume":"3","author":"Ji","year":"2007","journal-title":"Mol Pain"},{"key":"10.1016\/j.adaj.2020.08.019_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainres.2011.10.016","article-title":"Activation of satellite glial cells in lumbar dorsal root ganglia contributes to neuropathic pain after spinal nerve ligation","volume":"1427","author":"Liu","year":"2012","journal-title":"Brain Res"},{"issue":"11","key":"10.1016\/j.adaj.2020.08.019_bib26","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/0028-3908(94)90051-5","article-title":"The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat","volume":"33","author":"Meller","year":"1994","journal-title":"Neuropharmacology"},{"issue":"36","key":"10.1016\/j.adaj.2020.08.019_bib27","doi-asserted-by":"crossref","first-page":"11161","DOI":"10.1523\/JNEUROSCI.3365-09.2009","article-title":"Astroglia in medullary dorsal horn (trigeminal spinal subnucleus caudalis) are involved in trigeminal neuropathic pain mechanisms","volume":"29","author":"Okada-Ogawa","year":"2009","journal-title":"J\u00a0Neurosci"},{"issue":"2","key":"10.1016\/j.adaj.2020.08.019_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/jpet.103.052407","article-title":"Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy","volume":"306","author":"Raghavendra","year":"2003","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"11","key":"10.1016\/j.adaj.2020.08.019_bib29","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nm.2234","article-title":"Interactions between the immune and nervous systems in pain","volume":"16","author":"Ren","year":"2010","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.adaj.2020.08.019_bib30","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1046\/j.1471-4159.2003.01969.x","article-title":"Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing","volume":"86","author":"Svensson","year":"2003","journal-title":"J\u00a0Neurochem"},{"issue":"6950","key":"10.1016\/j.adaj.2020.08.019_bib31","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nature01786","article-title":"P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury","volume":"424","author":"Tsuda","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.adaj.2020.08.019_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0304-3959(97)03369-1","article-title":"Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat","volume":"71","author":"Watkins","year":"1997","journal-title":"Pain"},{"issue":"15","key":"10.1016\/j.adaj.2020.08.019_bib33","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/glia.20872","article-title":"Altered functional properties of satellite glial cells in compressed spinal ganglia","volume":"57","author":"Zhang","year":"2009","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.adaj.2020.08.019_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.gt.3303054","article-title":"HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia","volume":"15","author":"Zhou","year":"2008","journal-title":"Gene Ther"},{"issue":"11","key":"10.1016\/j.adaj.2020.08.019_bib35","first-page":"1230","article-title":"The prevalence of chronic pain in United States adults: results of an Internet-based survey","volume":"11","author":"Johannes","year":"2010","journal-title":"J\u00a0Pain"},{"issue":"8","key":"10.1016\/j.adaj.2020.08.019_bib36","first-page":"769","article-title":"Estimates of pain prevalence and severity in adults: United States, 2012","volume":"16","author":"Nahin","year":"2015","journal-title":"J\u00a0Pain"},{"issue":"6","key":"10.1016\/j.adaj.2020.08.019_bib37","first-page":"317","article-title":"Population-based survey of pain in the United States: differences among white, African American, and Hispanic subjects","volume":"5","author":"Portenoy","year":"2004","journal-title":"J\u00a0Pain"},{"issue":"2","key":"10.1016\/j.adaj.2020.08.019_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.280.2.147","article-title":"Persistent pain and well-being: a World Health Organization study in primary care","volume":"280","author":"Gureje","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.adaj.2020.08.019_bib39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/fampra\/18.3.292","article-title":"The impact of chronic pain in the community","volume":"18","author":"Smith","year":"2001","journal-title":"Fam Pract"},{"issue":"5","key":"10.1016\/j.adaj.2020.08.019_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1037\/a0013628","article-title":"Opioids and the treatment of chronic pain: controversies, current status, and future directions","volume":"16","author":"Rosenblum","year":"2008","journal-title":"Exp Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.adaj.2020.08.019_bib41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/070674370805300403","article-title":"Epidemiology of chronic pain with psychological comorbidity: prevalence, risk, course, and prognosis","volume":"53","author":"Tunks","year":"2008","journal-title":"Can J Psychiatry"},{"issue":"159","key":"10.1016\/j.adaj.2020.08.019_bib42","first-page":"1","article-title":"Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02","author":"Schappert","year":"2006","journal-title":"Vital Health Stat 13"},{"issue":"13","key":"10.1016\/j.adaj.2020.08.019_bib43","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain: misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.adaj.2020.08.019_bib44","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.adaj.2020.08.019_bib45","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1177\/0022034516657070","article-title":"Pain mechanisms and centralized pain in temporomandibular disorders","volume":"95","author":"Harper","year":"2016","journal-title":"J\u00a0Dent Res"},{"issue":"2","key":"10.1016\/j.adaj.2020.08.019_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/acm.1998.4.189","article-title":"Chinese medicine users in the United States, part II: preferred aspects of care","volume":"4","author":"Cassidy","year":"1998","journal-title":"J\u00a0Altern Complement Med"},{"issue":"1","key":"10.1016\/j.adaj.2020.08.019_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1592\/phco.20.1.83.34658","article-title":"Assessment of patients' perceptions and beliefs regarding herbal therapies","volume":"20","author":"Klepser","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.adaj.2020.08.019_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1067\/mtc.2000.107339","article-title":"Use of alternative medicine by patients undergoing cardiac surgery","volume":"120","author":"Liu","year":"2000","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.adaj.2020.08.019_bib49","first-page":"224","article-title":"Use of complementary and alternative medicine for temporomandibular disorders","volume":"17","author":"DeBar","year":"2003","journal-title":"J\u00a0Orofac Pain"},{"issue":"2","key":"10.1016\/j.adaj.2020.08.019_bib50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.37734","article-title":"Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels","volume":"65","author":"Younger","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.adaj.2020.08.019_bib51","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1526-4637.2009.00613.x","article-title":"Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study","volume":"10","author":"Younger","year":"2009","journal-title":"Pain Med"},{"issue":"144","key":"10.1016\/j.adaj.2020.08.019_bib52","first-page":"197","article-title":"Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone","volume":"26","author":"Oaks","year":"2018","journal-title":"Discov Med"},{"issue":"2","key":"10.1016\/j.adaj.2020.08.019_bib53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/biomedicines5020016","article-title":"Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia","volume":"5","author":"Parkitny","year":"2017","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.adaj.2020.08.019_bib54","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.psym.2011.11.006","article-title":"Is fibromyalgia an endocrine\/endorphin deficit disorder? Is low dose naltrexone a new treatment option?","volume":"53","author":"Ramanathan","year":"2012","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.adaj.2020.08.019_bib55","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1016\/j.brs.2018.12.216","article-title":"Proceedings #47: low dose naltrexone: a viable alternative for long term chronic pain?","volume":"12","author":"Rivera","year":"2019","journal-title":"Brain Stimul"},{"issue":"3","key":"10.1016\/j.adaj.2020.08.019_bib56","first-page":"197","article-title":"Low-dose naltrexone: a new therapy option for complex regional pain syndrome type I patients","volume":"20","author":"Sturn","year":"2016","journal-title":"Int J Pharm Compound"}],"container-title":["The Journal of the American Dental Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817720306346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817720306346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T04:10:04Z","timestamp":1757563804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002817720306346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0002817720306346"],"URL":"https:\/\/doi.org\/10.1016\/j.adaj.2020.08.019","relation":{},"ISSN":["0002-8177"],"issn-type":[{"value":"0002-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of low-dose naltrexone in the management of chronic pain conditions","name":"articletitle","label":"Article Title"},{"value":"The Journal of the American Dental Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adaj.2020.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Dental Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}